Indoleamine 2,3-dioxygenase 1 (IDO1), an enzyme that catalyzes the breakdown of tryptophan to kynurenine, is constitutively expressed by a wide variety of human tumor cell types as well as by dendritic cells that localize to tumor-draining lymph nodes [5, 6]. This evidence concerns the gene IDO1 and neoplasm.